Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer

Adrienne Melck, Hamid Masoudi, Obi L. Griffith, Ashish Rajput, Graeme Wilkins, Sam Bugis, Steven J.M. Jones, Sam M. Wiseman

Research output: Contribution to journalArticle

33 Scopus citations

Abstract

Background: Differentiated thyroid cancer (DTC) generally has a favorable outcome, but some patients develop local recurrence and/or distant metastases and ultimately die of their disease. Molecular markers that accurately predict tumor behavior are lacking. This study's aim was to ascertain the role of cell cycle regulators in predicting malignant histology and tumor behavior in DTC. Methods: Tissue microarrays consisting of 100 benign and 105 malignant thyroid lesions, plus 24 lymph node samples, were stained for p16, p21, p27, p53, p57, p63, cyclin D1, cyclin E, and mdm2. Statistical analysis was used to compare the expression of the markers in benign versus DTC lesions and correlate their expression with clinicopathologic characteristics. Results: p16, p21, cyclin D1, and cyclin E showed significantly (P < .001) increased expression in DTCs compared with benign thyroid lesions (54.7% vs. 5%, 71.7% vs. 38%, 87.1% vs. 45.7%, and 72.3% vs. 37.4%, respectively). There was no significant difference in expression between benign lesions and DTC for the remaining markers. p16 expression correlated significantly with extrathyroidal tumor extension (P = .02) and the presence of cancer in lymph nodes (P = .03). A total of 73% vs. 45% of the cancers of patients with and without lymph node involvement, respectively, stained positive for p16 (P = .01). Conclusions: There is a statistically significant difference in the expression of p16, p21, cyclin D1, and cyclin E between DTCs and benign thyroid lesions, and p16 expression correlates with clinicopathologic variables predicting poor outcomes for DTC. These results suggest that evaluation of cell cycle derangement in thyroid tumors may serve as a useful tool for both DTC diagnosis and prognosis.

Original languageEnglish
Pages (from-to)3403-3411
Number of pages9
JournalAnnals of Surgical Oncology
Volume14
Issue number12
DOIs
StatePublished - Dec 1 2007
Externally publishedYes

Keywords

  • Cell cycle regulators
  • Thyroid cancer
  • Tissue microarray

Fingerprint Dive into the research topics of 'Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer'. Together they form a unique fingerprint.

  • Cite this

    Melck, A., Masoudi, H., Griffith, O. L., Rajput, A., Wilkins, G., Bugis, S., Jones, S. J. M., & Wiseman, S. M. (2007). Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer. Annals of Surgical Oncology, 14(12), 3403-3411. https://doi.org/10.1245/s10434-007-9572-8